Literature DB >> 25889772

Validation of Varian's SmartAdapt® deformable image registration algorithm for clinical application.

Ihab S Ramadaan1,2, Karsten Peick3, David A Hamilton4, Jamie Evans5, Douglas Iupati6, Anna Nicholson7, Lynne Greig8, Robert J W Louwe9.   

Abstract

BACKGROUND: Re-contouring of structures on consecutive planning computed tomography (CT) images for patients that exhibit anatomical changes is elaborate and may negatively impact the turn-around time if this is required for many patients. This study was therefore initiated to validate the accuracy and usefulness of automatic contour propagation for head and neck cancer patients using SmartAdapt® which is the deformable image registration (DIR) application in Varian's Eclipse™ treatment planning system.
METHODS: CT images of eight head and neck cancer patients with multiple planning CTs were registered using SmartAdapt®. The contoured structures of target volumes and OARs of the primary planning CT were deformed accordingly and subsequently compared with a reference structure set being either: 1) a structure set independently contoured by the treating Radiation Oncologist (RO), or 2) the DIR-generated structure set after being reviewed and modified by the RO.
RESULTS: Application of DIR offered a considerable time saving for ROs in delineation of structures on CTs that were acquired mid-treatment. Quantitative analysis showed that 84% of the volume of the DIR-generated structures overlapped with the independently re-contoured structures, while 94% of the volume overlapped with the DIR-generated structures after review by the RO. This apparent intra-observer variation was further investigated resulting in the identification of several causes. Qualitative analysis showed that 92% of the DIR-generated structures either need no or only minor modification during RO reviews.
CONCLUSIONS: SmartAdapt is a powerful tool with sufficient accuracy that saves considerable time in re-contouring structures on re-CTs. However, careful review of the DIR-generated structures is mandatory, in particular in areas where tumour regression plays a role.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25889772      PMCID: PMC4465143          DOI: 10.1186/s13014-015-0372-1

Source DB:  PubMed          Journal:  Radiat Oncol        ISSN: 1748-717X            Impact factor:   3.481


Background

CT-images used for radiotherapy planning constitute only a snapshot in time of the patient’s anatomy before the start of radiotherapy. The whole treatment commonly involves 25–35 fractions, and is delivered in a time span of several weeks. During this period, the patient may undergo significant anatomical changes as a result of weight loss, tumour shrinkage or inflammation that affect the size, shape, and location of target volumes and organs at risk (OARs) [1]. Such changes can result in reduced doses to target volumes and/or increased doses to OARs [1,2] that necessitates adapting the treatment plan. Adaptive radiotherapy uses additional images to adjust the original treatment plan and counteract these anatomical changes [3-5]. However, frequent adaptation of treatment plans may substantially increase clinical workload and requires automation of several stages of treatment preparation to do this in a safe and efficient manner. At the Wellington Blood and Cancer Centre (WBCC), on-treatment imaging using a cone beam CT (CBCT) is used to verify the reproducibility of patient positioning and assess possible changes in the anatomy of the patient. As the impact of anatomical changes and/or patient positioning strongly depends on the individual patient and the details of the treatment plan, no general rules are applied to indicate re-CTs and re-planning at the WBCC. Rather, on-treatment imaging is reviewed weekly on an individual patient basis by a multi-disciplinary team of radiation therapists, medical physicists and radiation oncologists to verify the reproducibility of patient positioning and assess anatomical changes. If this raises concern regarding target coverage or OAR sparing, a re-CT is indicated. Subsequently, the initial treatment plan is copied onto the new CT, and the dosimetric changes are assessed. If these dosimetric changes show that the target coverage or OAR sparing may be compromised, the relevant anatomical structures are re-contoured by the RO and a new treatment plan is created. Re-contouring of all relevant structures is time consuming and limits the number of patients for whom plan adaptation can be achieved in a short turn-around time. Deformable Image Registration (DIR) may be useful to quantify the detected anatomical changes and to automate re-contouring of anatomical structures after an anatomical change has been observed. Clinical implementation of DIR has been validated by several groups [6-8]. However, these studies did not include all aspects that were relevant to DIR implementation at the WBCC. For instance, none of these studies specifically addressed the accuracy of DIR when applied to a contrast-enhanced planning CT and a non-contrast enhanced repeat CT, or investigated the time gained for ROs to review and modify DIR-generated structures instead of re-contouring structures from ‘scratch’. Furthermore, Hardcastle et al. [6] investigated two DIR algorithms that are available in Pinnacle (Philips Medical Systems, Andover, MA), but are different from the ‘accelerated demons’ algorithm available to Varian users. The clinical implementation of the latter algorithm was validated by Wang et al. [7] using the original, in-house developed version of the ‘accelerated demons’ algorithm by the same group [9]. It seems highly likely that additional modifications were made to this original source code for the commercial implementation in Varian’s SmartAdapt®. For instance, the previous version of SmartAdapt (v.10) offered the option to either include smoothing in the DIR process or not, while the current version (v.11) as used at the WBCC only offers the ‘standard DIR algorithm’ and has fixed parameter settings. Finally, Eiland et al. [8] did use the same version of SmartAdapt as currently available at the WBCC, but used a different approach involving the DIR of the planning CT to an on-treatment Cone Beam CT, which is not applicable for the workflow investigated in this study. These observations warranted an independent validation of the DIR implementation in Varian’s SmartAdapt® at the WBCC. Therefore, this retrospective study was started to validate the clinical implementation of DIR, and it specifically reports on: The DIR accuracy in adapting structures using Varian’s SmartAdapt®; Differences between delineated structures either modified after DIR by an RO or contoured from ‘scratch’ as per current protocol; The DIR accuracy when registering a contrast-enhanced planning CT and a non-contrast enhanced repeat CT; Quantitative and qualitative analysis of the results obtained for the gross target volume (GTV), clinical target volumes (CTVs) for all dose prescription levels as well as multiple OARs: brain stem, spinal cord and both parotid glands; Time saving compared to the current clinical workflow at the WBCC.

Methods and materials

Patient selection

This study was carried out retrospectively using the data of eight head and neck cancer patients treated at the WBCC treated by four ROs (Table 1). Multiple planning CTs were available for the selected patients, either because anatomical changes were observed during treatment or because the CT position could not be reproduced during treatment with sufficient accuracy to warrant safe treatment. All patient plans and image sets selected were anonymized, and clinically contoured structures were copied to a non-clinical test database. For each patient, the first CT scan was acquired with iodine-based CT contrast administered but subsequent CTs were acquired without CT contrast. The slice thickness for all CTs was 3 mm. For two patients (P2 and P7), a third CT scan acquired during the course of treatment was available.
Table 1

Clinical information for the 8 head and neck cancer patients included in this study

P1 P2 P3 P4 P5 P6 P7 P8
Tumour Site L TonsilL TonsilR TonsilNasopharynxL TongueR TonsilPara-nasal sinusTongue
No. fractions 3030303030303030
Surgery YesNoNoNoYesNoYesNo
Staging T2N1M0T3N2bM0T1N0M0T1N0M0T2N2bM0T2N2M0T4N2M0T4N3aM0
GTV [ cm 3 ] 14.1a 88.826.282.8-47.5-201.1
CTV 50–54 [cm 3 ] 201.8446.1144.6567.5299.4314.1-179.1b
CTV 60 [cm 3 ] ----214.3-583.4331.7
CTV 66 [cm 3 ] 68.5186.838.8153.257.7108.1--
Additional imaging PETPET-MRIMRI-MRI-
Number of CTs 23222232
Days after CT 1 4226/423630253542/6931
Days after RT start 258/2421167-c -c/2020
Weight change between CTs [kg] −7.1−10.7/+0.8−1.3−3.8−2.60.0+1.6/- 0.8−6.8
Reason for re- CT Tumour shrinkagePatient positionSwellingPatient positionSwellingPatient positionPatient positionTissue Loss
New Mask YesYes/NoYesNoNoNoNo/NoNo
New plan YesYes/YesYesNoNoNoNA/NoNo

aThis GTV represents a node that was not removed during surgery.

bThe low dose CTV for this patient was adjacent to and did not include the high dose CTV as usual.

cInitial start of RT was delayed due to clinical reasons. Second CT was acquired prior to actual start of RT.

Clinical information for the 8 head and neck cancer patients included in this study aThis GTV represents a node that was not removed during surgery. bThe low dose CTV for this patient was adjacent to and did not include the high dose CTV as usual. cInitial start of RT was delayed due to clinical reasons. Second CT was acquired prior to actual start of RT.

Structure selection

A number of structures as contoured by the RO during the treatment preparation phase were common in most data sets and therefore selected for analysis in this study: GTV, CTVs, spinal cord, parotid glands, and the brainstem. PTVs were not included in the analysis as these structures would not be included in the DIR process in a clinical setting but would be re-created by expanding the adapted CTV after DIR. In addition to the selected structures, the C4 vertebra which is not expected to deform in between consecutive CT scans was selected as a reference structure to verify the accuracy of the DIR process. This structure was delineated by the first author.

Workflow

CT sets of each patient were first rigidly registered using bony anatomy as a starting point before further registration using DIR. In the latter step, the structures of interest linked to the first CT image were deformed as defined by the deformation vector field resulting from the DIR process. In order to investigate the feasibility of the intended clinical workflow, the DIR-generated contours were reviewed and if necessary modified by the treating ROs. However, these RO-modified contours could potentially include a bias towards pre-defined structures when testing the accuracy of the DIR algorithm. Therefore, another test was conducted in addition where each RO independently re-contoured the structures on the re-CT image using his/her clinical notes as well as the original structure set, but without reference to the DIR-generated structures. The DIR generated structures for the third CT scans acquired for patients P2 and P7, were obtained using the second CT scan and corresponding clinical structures as the reference data set. In addition to determining the accuracy of the DIR algorithm for clinical application, the results of the two tests were compared to investigate a potential bias when the structures resulting from DIR are only reviewed and adapted prior to clinical application, instead of completely re-contouring all structures when a new CT has been acquired. For that purpose, all data was analysed both quantitatively and qualitatively as described below.

Quantitative analysis

For quantitative analysis, the RO-drawn contours and the DIR-generated contours were first converted into high resolution structures as they are available in Eclipse v.11 to improve the accuracy of the next analysis step. This improves the in-plane resolution of the structures but not the resolution in the longitudinal direction which is determined by the 3 mm CT-slice thickness. The next step comprised a Boolean ‘AND’- operation in the contouring module of Eclipse to determine the volumetric overlap between the RO-drawn contours and the DIR-generated contours. Subsequently, the obtained volume data were used to calculate the Dice Similarity Index (DSI) [10], which in this study represents the percentage volume overlap of two presentations A and A’ of a structure: where V represents the volume of a structure. Statistical tests were carried out using Matlab (The Mathworks, Natick, MA, USA).

Qualitative analysis

For qualitative analysis, the differences between RO-drawn and DIR-generated structures were reviewed together with the treating RO. Discrepancies between the two structures were investigated in consultation with clinical notes and the agreement between the two contours was assessed using a pre-defined scoring system based on a scale of 1–4: The DIR-generated contour is more accurate than the RO-drawn contour The differences between the DIR-generated contour and RO-drawn contour are minimal when clinically acceptable without modification The DIR-generated contour can be accepted after minor modification The DIR-generated contour requires major modification and is therefore unusable. This scoring system is equal to the system used by Hardcastle et al. [6] except that the above scoring system has the first category additional to it. This category was specifically added to this scoring system considering that intra-observer variation is an important factor in head-and-neck radiation oncology and could in principle yield such scores. For instance, the DIR may produce a more consistent result based on the initial RO contours and the change in shape revealed by the change in voxel intensities in the two CT images.

Time saving

During a pilot study that included the first five tests of this study, the RO was asked to retrospectively estimate the time required to edit the contours, effectively within a range of 10 minutes. However for all subsequent tests, the time required to either edit the contours or to delineate the structures de novo by the ROs was actually recorded to improve the accuracy of the estimated possible time saving after clinical implementation of SmartAdapt.

Deformable image registration software and algorithm

The DIR software programme used in this study was the SmartAdapt® module of the Eclipse™ v.11 Treatment Planning System (TPS) from Varian (Varian Medical Systems Inc., Palo Alto, CA). This application employs a Modified Demons-based DIR algorithm [9,11]. Modification of algorithm parameters or boundary conditions that can potentially affect the DIR results could not be investigated as these are fixed in the implementation of DIR in this version of SmartAdapt.

Results

Accuracy of DIR generated structures

The DSI scores of the overlap between the DIR generated structures and those independently re-contoured by an RO for the 2nd CT scan of P1-P8 were on average 0.82 ± 0.08 (1 S.D.) and had a range of 0.54-0.96 (Table 2). All DSI scores appeared to be lower than expected, in particular the DSI scores for the OARs for most patients. In addition, the average DSI scores seem to vary from patient to patient, with very low DSI scores for P8 in particular for whom the CT images did display a poor soft-tissue contrast. A Kruskal-Wallis test including a post-hoc test using a Bonferroni correction for multiple comparisons [12,13] showed that the difference between the average DSI score for patient P8 was significantly lower than those obtained for patients P1-P7 (p < 0.01). Similarly, it could be shown that the average DSI score for the spinal cord was significantly lower than those for other structures (p < 0.01), while the average DSI score for the right parotid was not significantly lower (p = 0.18).
Table 2

DSI scores reflecting the overlap between the DIR-generated and RO re-contoured structures on a repeat CT-scan

P1 P2 P3 P4 P5 P6 P7 P8 Mean S.D
GTV 0.800.830.840.890.930.77 0.84 0.06
CTV 54 0.880.890.840.870.910.920.84 0.88 0.03
CTV 60 0.910.880.86 0.89 0.02
CTV 66 0.850.920.820.890.870.94 0.88 0.04
Brain Stem 0.830.960.670.920.880.910.800.68 0.83 0.11
Spinal Cord 0.780.840.730.750.740.780.770.63 0.75 0.06
R Parotid 0.730.760.790.740.900.900.770.54 0.77 0.11
L Parotid 0.820.770.840.860.820.910.820.71 0.82 0.06
Mean 0.81 0.85 0.79 0.84 0.86 0.90 0.81 0.72
S.D. 0.05 0.07 0.07 0.07 0.06 0.05 0.05 0.12

CTVx denotes the clinical target volume with a dose prescription of x Gy.

DSI scores reflecting the overlap between the DIR-generated and RO re-contoured structures on a repeat CT-scan CTVx denotes the clinical target volume with a dose prescription of x Gy.

Analysis of a potential bias

On average the DSI scores of the overlap between DIR generated and RO-modified structures were 0.93 ± 0.08 (1 S.D.) (Table 3). A histogram of the differences between the individual DSI scores of the two tests showed that the DSI scores reflecting the overlap of the DIR-generated and RO re-contoured structures are lower than those reflecting the overlap of the DIR generated and RO-modified structures in nearly all cases (Figure 1). A paired two-sided Wilcoxon sign rank test confirmed that this difference was statistically significant (p < 0.001). This difference may reflect intra-observer variation, but the significantly higher DSI scores close to unity for the RO-modified structures also indicate that there is probably a bias towards approving the DIR generated structures and possibly only a limited number of changes would be made in a clinical setting. This apparent bias also reduced the differences in DSI scores between specific patients and structures that were observed previously for the overlap between DIR-generated and RO-drawn contours. For the overlap of RO-modified structures and DIR-generated structures, none of the average DSI scores of specific patients and structures were significantly different (p > 0.05).
Table 3

DSI scores reflecting the overlap between the DIR-generated and RO-modified structures on a repeat CT-scan

P1 P2 P3 P4 P5 P6 P7 P8 Mean S.D
GTV0.900.830.990.970.980.97 0.94 0.06
CTV540.950.970.990.980.990.990.96 0.98 0.01
CTV600.990.940.97 0.96 0.03
CTV660.970.870.950.980.980.98 0.95 0.04
Brain Stem0.861.000.680.980.980.950.870.65 0.87 0.14
Spinal Cord1.000.950.820.890.890.910.770.91 0.89 0.07
R Parotid0.891.001.000.980.980.950.900.95 0.95 0.04
L Parotid0.931.000.880.980.970.940.850.74 0.91 0.09
Mean 0.93 0.94 0.90 0.97 0.97 0.96 0.86 0.88
S.D. 0.05 0.07 0.12 0.04 0.04 0.03 0.06 0.13

CTVx denotes the clinical target volume with a dose prescription of x Gy.

Figure 1

Histogram of the differences between DSI scores for RO re-contoured and RO-modified structures. The bars include the data of all structures of patients P1-P8 as displayed in Tables 1 and 2.

DSI scores reflecting the overlap between the DIR-generated and RO-modified structures on a repeat CT-scan CTVx denotes the clinical target volume with a dose prescription of x Gy. Histogram of the differences between DSI scores for RO re-contoured and RO-modified structures. The bars include the data of all structures of patients P1-P8 as displayed in Tables 1 and 2.

Impact of registering contrast-enhanced and non-enhanced CT scans

Three CT-scans and corresponding structures were available for patients P2 and P7, where only the original planning CT was contrast-enhanced and both re-CTs were registered to the most recent CT-scan. The DSI scores observed for P2 and P7, for a pair of CT images with only one contrast-enhanced CT image on one hand, and two non-enhanced CT-images on the other hand, did not show a systematic difference in DIR performance (Table 4). However, the comparison above could only be made for two patients. Therefore, no conclusion could be made concerning a possible contribution of registering non-enhanced re-CTs and contrast-enhanced initial planning CT images to the relatively low DSI scores in Table 2.
Table 4

DSI scores reflecting the overlap between DIR-generated and RO re-contoured structures for CT2 and CT3

P2 P7
CT2 CT3 CT2 CT3
GTV 0.830.66
CTV 54 0.890.87
CTV 60 0.880.89
CTV 66 0.920.79
Brain Stem 0.960.840.800.82
Spinal Cord 0.840.750.770.79
R Parotid 0.760.820.770.74
L Parotid 0.770.830.820.81
Mean 0.85 0.79 0.81 0.81
S.D. 0.07 0.07 0.05 0.05

CTVx denotes the clinical target volume with a dose prescription of x Gy.

DSI scores reflecting the overlap between DIR-generated and RO re-contoured structures for CT2 and CT3 CTVx denotes the clinical target volume with a dose prescription of x Gy. The qualitative scores given by the ROs upon review of the DIR-generated structures and comparison with the re-contoured stuctures, showed that only 5 (8%) of the DIR-generated structures required major modifications and were not usable. Furthermore, 8 (12%), 29 (44%), and 24 (36%) of these structures were more accurate than the RO re-contoured structures, could be accepted without modifications, or required at most minor modifications, respectively. These scores showed only a weak correlation with the corresponding DSI scores (Figure 2), although DIR-generated structures that were deemed to require major modification (score 4) during qualitative review did exhibit a lower DSI score on average. For 6 delineated parotids, one GTV and one CTV, the DIR-generated structures were considered to be more accurate than the RO re-contoured structures (score 1) upon retrospective review by the RO. It was estimated that for these cases, limitations in soft-tissue contrast of the CT images resulted in intra-observer variation reflected by small differences in delineation.
Figure 2

Relation between quantitative and qualitative analysis results. Solid markers: DSI scores reflecting the overlap between DIR-generated structures and the RO re-contoured structures as a function of the qualitative assessment score upon review by the RO.

Relation between quantitative and qualitative analysis results. Solid markers: DSI scores reflecting the overlap between DIR-generated structures and the RO re-contoured structures as a function of the qualitative assessment score upon review by the RO. The average time required to either re-contour, or to review and modify DIR-generated structures on the 2nd and 3rd CT images was 67 ± 30 (1 S.D.) and 29 ± 8 (1 S.D.) minutes, respectively (Table 5). In one case (P6), re-contouring of the relevant structures was slightly faster than adapting the DIR-generated structures. However, time saving for the ROs was observed for all other cases, with the average time difference equal to 38 ± 25 (1 S.D.) minutes. A paired t-test showed that the difference in required time was significant (p < 0.001).
Table 5

Time required by the ROs in minutes to adapt DIR-generated structures or re-contoured structures from scratch

Patient CT set Adapt Re-contour Gain
P1CT230 (±10)54(±1)24
P2CT230(±10)86(±1)56
P2CT330(±10)90(±1)60
P3CT230(±10)89(±1)59
P4CT230(±10)72(±1)42
P5CT230(±10)50(±1)20
P6CT227(±1)20(±1)−7
P7CT221(±1)45(±1)24
P7CT315(±1)44(±1)29
P8CT245(±1)120(±1)75
Mean 29 67 38
S.D. 8 30 25

The values between brackets represent the maximum range of the estimated/measured time (see text).

Time required by the ROs in minutes to adapt DIR-generated structures or re-contoured structures from scratch The values between brackets represent the maximum range of the estimated/measured time (see text).

Discussion

A commercially available DIR package was evaluated at the WBCC to verify its reliability and usefulness to generate an updated structure set for re-CT images that are occasionally acquired to verify the validity of a treatment of a patient. This evaluation revealed that only minor volumetric changes are made to DIR-generated structures upon review by an RO. Quantitative analysis showed that on average 93% of the volume of the RO-modified structures overlap with the DIR-generated structures. However, considerably smaller volumetric overlap (82%) was observed between the DIR-generated structures with those that were independently re-contoured by an RO. This highlights that there is a potential bias towards approving DIR-generated structures in a clinical setting. However, it should be noted that this bias is likely also accompanied by a decrease in intra-observer variation after implementation of DIR (see further below).

Differences between DSI scores of structures or patients

The average DSI scores for the overlap between DIR-generated and RO-drawn contours were found to be significantly different for patient P8 and for the spinal cord. These differences may have been related to poor soft-tissue contrast that was specifically noted for P8 and is not uncommon for parts of the spinal cord. However, the average DSI scores were not significantly different for the parotids where it may have been expected as well. It should be noted that with multiple ROs, each delineating the structures of a single patient, and the variation of structures between the various patients, the data set is relatively inhomogeneuous, and the results of statistical testing should be interpreted with caution. Furthermore, the absence of significant differences for specific patients or structures when comparing the average DSI scores of the overlap between DIR-generated and RO-modified contours is likely caused by the bias towards approving DIR-generated contours.

Differences between quantitative and qualitative results

Qualitative analysis of the results using a pre-defined scoring system at the review of the DIR-generated structures by an RO showed only a weak correlation with the DSI scores calculated during quantitative analysis (Figure 2). However, the two analysis methods are fundamentally different and are complementary in a number of aspects. For instance, contour changes that are scored as minor changes during qualitative analysis do not always represent the same change in volumetric overlap. Furthermore, qualitative analysis and scoring include the clinical relevance of discrepancies and are accordingly prioritised as judged by an RO. In a clinical setting, these considerations will be fundamental in approving DIR-generated structures while small inaccuracies, for instance in delineation of the spinal cord at locations well away from the irradiated volume, will generally be dismissed in a clinical setting. Therefore, the results of the qualitative analysis based on the review of results by the ROs were considered to be pivotal in the assessment of the accuracy and usefulness of the DIR package in this study. This qualitative analysis showed that the majority of DIR-generated structures could be approved after some modification, and that DIR resulted in a considerable time saving. The role of the quantitative analysis was to highlight potential failure modes such as bias towards approving DIR-generated structures, inconsistencies in contouring, and intra-observer variability.

Review of discrepancies

Further inspection of overlap between DIR generated and RO re-contoured structures revealed a number of common causes for discrepancies: Limitations in soft-tissue contrast in CT images Limitations in soft-tissue contrast in CT imaging hamper accurate delineation of specific organs such as parotids, spinal cord and brain stem. In addition, the distinction between individual vertebrae that are compressed, or between the external patient contour and build-up material, can be difficult. As the DIR algorithm uses the differences in Hounsfield units (HUs) to track patient deformation, these limitations may result in a lower DSI score. Figure 3a,b displays an example of this limitation resulting in a low DSI score for the spinal cord.
Figure 3

Comparison of DIR-generated (purple), RO re- contoured (green), and initially delineated planning CT structures (yellow). Panels (a/b) show an example where the low soft-tissue contrast induced an incorrect shift of DIR-generated structure of the spinal cord; (c) intra-observer variation in the delineation of the brain stem; (d) uncertainty at the cranial and caudal boundary of C4 delineation due to limited slice resolution; (e/f) difference between DIR-generated and the RO-modified CTV after tumour regression.

Intra-observer variation For a number of delineated structures, considerable differences were observed between the delineation of the same structure on the two consecutive CTs. Inspection of the scan acquisition settings revealed a variation in mAs settings but this did not noticeably affect the soft-tissue contrast of the CT images in this study. Although limitations in soft-tissue contrast may be an important cause of intra-observer variation, some of the observed differences clearly reflected a difference in interpretation of the two CT images that could not be explained by limitations in soft-tissue contrast only. Furthermore, some discrepancies were caused by the availability of new and/or additional information in clinical notes. Figure 3c shows an example of intra-observer variation in delineation of the brainstem. Differences in CT-contrast enhancement Although no systematic difference between the DSI scores for data sets with or without contrast enhanced CT images could be demonstrated, it was estimated that contrast enhancement did impact the accuracy of the DIR result in a number of cases where structures were proximal to relatively large blood vessels. Errors due to a limited CT slice resolution The CT slice resolution applied for treatment preparation in this study was 3 mm which is the default CT slice resolution for the majority of patients at the WBCC. Any uncertainty in the actual deformation at the superior and inferior ends of delineated structures can therefore potentially result in a 3 mm error at these locations and a decrease in overlap of DIR-generated and RO re-contoured structures. Figure 3d displays an example of this limitation resulting in a low DSI score for C4. Clinical target volume not adapted for tumour shrinkage during treatment Tumour shrinkage in between the two consecutive CT images was observed for a number of patients. In those instances the DIR algorithm seemed to be able to closely track this phenomenon. However, as no proof exists that all microscopic lesions have been sterilised, changes to the CTV during the course of treatment are usually only applied very reluctantly. This was observed for a number of cases and contributed to a lower DSI score (Figure 3e-f). Comparison of DIR-generated (purple), RO re- contoured (green), and initially delineated planning CT structures (yellow). Panels (a/b) show an example where the low soft-tissue contrast induced an incorrect shift of DIR-generated structure of the spinal cord; (c) intra-observer variation in the delineation of the brain stem; (d) uncertainty at the cranial and caudal boundary of C4 delineation due to limited slice resolution; (e/f) difference between DIR-generated and the RO-modified CTV after tumour regression.

Observer variability

Intra and inter-observer variability in structure delineation in head-and-neck radiotherapy has been described by numerous authors [14-17]. Similarly, in this study several examples of intra-observer variability could be identified. Review of the discrepancies between the structure sets by an RO and a physicist revealed a number of common causes for these differences including poor image contrast, and the impact of a limited CT slice resolution. In addition, re-contouring clinical target volumes on a re-CT acquired mid-treatment where tumour regression or other changes in anatomy may be observed is subject to interpretation based on limited information and therefore prone to considerable observer variation [6,18]. Nevertheless, it is obviously important to reduce observer variation in delineation as much as possible and several methods have been proposed in literature including review boards, multi-modality imaging, contouring atlases and protocols [15,19,20]. Also the application of DIR imposes consistency in contouring between consecutive CT images as it uses prior contouring as starting point [14]. However, as the accuracy of the delineation of structures on the first planning CT is prone to observer variability as well, the DIR-generated structures must always be carefully reviewed by the treating RO.

Comparison with other studies

Very similar DSI scores were found by a number of authors compared to those reported in this study. Chao et al. studied the reduction in delineation variation using DIR and found average DSI scores equal to 0.61 and 0.57 for the overlap between DIR-generated and independently drawn contours by ROs for base-of-tongue and nasopharyngeal tumours, respectively [14]. When the DIR-generated structures were only adapted by ROs, these DSI-scores improved to 0.90 and 0.88, respectively. Wang et al. found an improvement in average DSI-scores from 0.83 to 0.97 in a performance validation study of DIR [7]. Hardcastle et al. performed a multi-institutional evaluation of DIR algorithms and found average DSI scores of approximately 0.80 [6]. That study also applied a very similar qualitative analysis as the current study, reporting that 94% of the DIR-generated structures were usable but 6% of these required major modification, as compared to 92% and 8% in our study. Finally, Brouwer et al. reported concordance indices ranging between 0.64 – 0.71 for the overlap between DIR-generated structures and those independently contoured by several ROs for OARs excluding the thyroid cartilage [17]. As the concordance index is comparable with the DSI but tends to be lower for disjoint volumes, we estimate that these results are also very comparable to the results presented in this study.

Conclusions

We have shown that the SmartAdapt is a very useful and time-saving tool for DIR application to propagate the structures delineated on the primary planning CT to consecutive re-CTs. DIR provided reasonably accurate structures in 92% of the cases that required no or only minor modifications. However, careful review of the DIR-generated structures by the treating RO remains crucial, in particular where tumour shrinkage plays a role. Furthermore, this study highlighted the presence of considerable intra-observer variation similar to findings reported in literature previously.
  17 in total

1.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines.

Authors:  Vincent Grégoire; Peter Levendag; Kian K Ang; Jacques Bernier; Marijel Braaksma; Volker Budach; Cliff Chao; Emmanuel Coche; Jay S Cooper; Guy Cosnard; Avraham Eisbruch; Samy El-Sayed; Bahman Emami; Cai Grau; Marc Hamoir; Nancy Lee; Philippe Maingon; Karin Muller; Hervé Reychler
Journal:  Radiother Oncol       Date:  2003-12       Impact factor: 6.280

2.  Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach.

Authors:  K S Clifford Chao; Shreerang Bhide; Hansen Chen; Joshua Asper; Steven Bush; Gregg Franklin; Vivek Kavadi; Vichaivood Liengswangwong; William Gordon; Adam Raben; Jon Strasser; Christopher Koprowski; Steven Frank; Gregory Chronowski; Anesa Ahamad; Robert Malyapa; Lifei Zhang; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-08-01       Impact factor: 7.038

3.  Image matching as a diffusion process: an analogy with Maxwell's demons.

Authors:  J P Thirion
Journal:  Med Image Anal       Date:  1998-09       Impact factor: 8.545

4.  Adaptive radiotherapy: merging principle into clinical practice.

Authors:  Di Yan
Journal:  Semin Radiat Oncol       Date:  2010-04       Impact factor: 5.934

5.  Adaptive radiation therapy.

Authors:  D Yan; F Vicini; J Wong; A Martinez
Journal:  Phys Med Biol       Date:  1997-01       Impact factor: 3.609

6.  Deformable image registration for adaptive radiation therapy of head and neck cancer: accuracy and precision in the presence of tumor changes.

Authors:  Angelo Mencarelli; Simon Robert van Kranen; Olga Hamming-Vrieze; Suzanne van Beek; Coenraad Robert Nico Rasch; Marcel van Herk; Jan-Jakob Sonke
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-08-20       Impact factor: 7.038

7.  Validation of an accelerated 'demons' algorithm for deformable image registration in radiation therapy.

Authors:  He Wang; Lei Dong; Jennifer O'Daniel; Radhe Mohan; Adam S Garden; K Kian Ang; Deborah A Kuban; Mark Bonnen; Joe Y Chang; Rex Cheung
Journal:  Phys Med Biol       Date:  2005-06-01       Impact factor: 3.609

8.  A pre-clinical assessment of an atlas-based automatic segmentation tool for the head and neck.

Authors:  Richard Sims; Aurelie Isambert; Vincent Grégoire; François Bidault; Lydia Fresco; John Sage; John Mills; Jean Bourhis; Dimitri Lefkopoulos; Olivier Commowick; Mehdi Benkebil; Grégoire Malandain
Journal:  Radiother Oncol       Date:  2009-09-14       Impact factor: 6.280

9.  Performance evaluation of automatic anatomy segmentation algorithm on repeat or four-dimensional computed tomography images using deformable image registration method.

Authors:  He Wang; Adam S Garden; Lifei Zhang; Xiong Wei; Anesa Ahamad; Deborah A Kuban; Ritsuko Komaki; Jennifer O'Daniel; Yongbin Zhang; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-09-01       Impact factor: 7.038

10.  Dosimetric and geometric evaluation of the use of deformable image registration in adaptive intensity-modulated radiotherapy for head-and-neck cancer.

Authors:  R B Eiland; C Maare; D Sjöström; E Samsøe; C F Behrens
Journal:  J Radiat Res       Date:  2014-06-06       Impact factor: 2.724

View more
  12 in total

1.  An evaluation of techniques for dose calculation on cone beam computed tomography.

Authors:  Valentina Giacometti; Raymond B King; Christina E Agnew; Denise M Irvine; Suneil Jain; Alan R Hounsell; Conor K McGarry
Journal:  Br J Radiol       Date:  2019-02-26       Impact factor: 3.039

2.  Feasibility of offline head & neck adaptive radiotherapy using deformed planning CT electron density mapping on weekly cone beam computed tomography.

Authors:  Anantharaman Ayyalusamy; Subramani Vellaiyan; Subramanian Shanmugam; Arivarasan Ilamurugu; Arun Gandhi; Thirumalaiswamy Shanmugam; Kathirvel Murugesan
Journal:  Br J Radiol       Date:  2016-10-26       Impact factor: 3.039

3.  Automatic contour segmentation of cervical cancer using artificial intelligence.

Authors:  Yosuke Kano; Hitoshi Ikushima; Motoharu Sasaki; Akihiro Haga
Journal:  J Radiat Res       Date:  2021-09-13       Impact factor: 2.724

4.  Spatiotemporal Free-Form Registration Method Assisted by a Minimum Spanning Tree During Discontinuous Transformations.

Authors:  Jang Pyo Bae; Siyeop Yoon; Malinda Vania; Deukhee Lee
Journal:  J Digit Imaging       Date:  2021-01-22       Impact factor: 4.056

5.  MIRSIG position paper: the use of image registration and fusion algorithms in radiotherapy.

Authors:  Nicholas Lowther; Rob Louwe; Johnson Yuen; Nicholas Hardcastle; Adam Yeo; Michael Jameson
Journal:  Phys Eng Sci Med       Date:  2022-05-06

6.  Evaluation of Deformable Image Registration-Based Contour Propagation From Planning CT to Cone-Beam CT.

Authors:  Andrew J Woerner; Mehee Choi; Matthew M Harkenrider; John C Roeske; Murat Surucu
Journal:  Technol Cancer Res Treat       Date:  2017-03-10

7.  RapidPlan head and neck model: the objectives and possible clinical benefit.

Authors:  A Fogliata; G Reggiori; A Stravato; F Lobefalo; C Franzese; D Franceschini; S Tomatis; P Mancosu; M Scorsetti; L Cozzi
Journal:  Radiat Oncol       Date:  2017-04-27       Impact factor: 3.481

8.  Deformable image registration for adaptive radiotherapy with guaranteed local rigidity constraints.

Authors:  Lars König; Alexander Derksen; Nils Papenberg; Benjamin Haas
Journal:  Radiat Oncol       Date:  2016-09-20       Impact factor: 3.481

9.  Registering prostate external beam radiotherapy with a boost from high-dose-rate brachytherapy: a comparative evaluation of deformable registration algorithms.

Authors:  Calyn R Moulton; Michael J House; Victoria Lye; Colin I Tang; Michele Krawiec; David J Joseph; James W Denham; Martin A Ebert
Journal:  Radiat Oncol       Date:  2015-12-14       Impact factor: 3.481

10.  Quantitative analysis of respiration-induced motion of each liver segment with helical computed tomography and 4-dimensional computed tomography.

Authors:  Yu-Lun Tsai; Ching-Jung Wu; Suzun Shaw; Pei-Chieh Yu; Hsin-Hua Nien; Louis Tak Lui
Journal:  Radiat Oncol       Date:  2018-04-02       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.